Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder

Overview of attention for article published in Neuropsychiatric Disease and Treatment, February 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

Effect of fluvoxamine on plasma interleukin-6 in patients with major depressive disorder: a prospective follow-up study

Article in Frontiers in Psychiatry (May 2023)

Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis

Article in European Neuropsychopharmacology (October 2022)

Effect of Fluvoxamine on Interleukin-6 Levels in COVID-19 Patients Hospitalized in ICU: A Randomized Clinical Trial.

Article in Respiration (February 2022)